UCAR Logo

UCAR

A nonprofit consortium of universities advancing atmospheric and Earth system sciences.

ALUCR | PA

Overview

Corporate Details

ISIN(s):
FR0011070457
LEI:
969500K8EPT7JBE7FP45
Country:
France
Address:
10 RUE LOUIS PASTEUR, 92100 BOULOGNE-BILLANCOURT

Description

The University Corporation for Atmospheric Research (UCAR) is a nonprofit consortium of over 120 member colleges and universities dedicated to advancing the atmospheric and related Earth system sciences. UCAR manages the National Science Foundation National Center for Atmospheric Research (NSF NCAR) and serves as a hub for the scientific community. It provides access to advanced research facilities, observing and computing resources, data and software services, and educational programs. The organization accelerates scientific discoveries and offers opportunities like internships, fellowships, and workshops to support students, early-career scientists, and established professionals.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2015-08-26 19:00
UCAR : Nombre d’actions et de droits de vote au 31 juillet 2015
French 390.3 KB
2015-08-26 18:35
UCAR : chiffre d’affaires au 30 juin 2015
French 411.7 KB
2015-07-15 18:45
Bilan semestriel du contrat de liquidité UCAR contracté avec la société AUREL B…
French 232.0 KB
2015-07-15 18:40
UCAR : Nombre d’actions et de droits de vote au 30 juin 2015
French 240.0 KB
2015-07-15 18:35
UCAR : Nombre d’actions et de droits de vote au 31 mai 2015
French 239.4 KB
2015-06-23 19:00
UCAR : Compte rendu AGM du 18 juin 2015 / Dividende de 0,20 € par action
French 548.5 KB
2015-06-19 14:00
UCAR : Apport complémentaire au contrat de liquidité
French 213.9 KB
2015-05-19 18:45
UCAR : Nombre d’actions et de droits de vote au 30 avril 2015
French 239.5 KB
2015-04-28 18:40
UCAR : résultats 2014
French 482.2 KB
2015-04-14 18:35
UCAR lance une offre pour les courts trajets à 10 euros / jour
French 767.5 KB
2015-03-25 18:10
UCAR confirme son éligibilité au PEA PME
French 457.8 KB
2015-02-19 17:45
UCAR : Nombre d’actions et de droits de vote au 31 janvier 2015
French 240.1 KB
2015-02-02 17:45
UCAR : Nombre d’actions et de droits de vote au 31 décembre 2014
French 239.3 KB
2014-12-15 17:50
UCAR : Nombre d’actions et de droits de vote au 30 novembre 2014
French 185.1 KB
2014-11-17 17:45
UCAR : Nombre d’actions et de droits de vote au 31 octobre 2014
French 185.1 KB

Automate Your Workflow. Get a real-time feed of all UCAR filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for UCAR

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for UCAR via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Adaptive Biotechnologies Corp Logo
Decodes the adaptive immune system to develop products for diagnosing and treating disease.
United States of America
ADPT
Adeia Inc. Logo
R&D company that licenses IP for the media, entertainment, and semiconductor industries.
United States of America
ADEA
Aditxt, Inc. Logo
Acquires, develops, and deploys health technologies to address major health challenges.
United States of America
ADTX
Advanced Biomed Inc. Logo
Develops microfluidic biochip diagnostic systems for precision oncology.
United States of America
ADVB
AIM ImmunoTech Inc. Logo
Immuno-pharma company developing therapeutics for oncology, immune, and viral diseases.
United States of America
AIM
Ainos, Inc. Logo
Develops AI-driven diagnostics, immune therapeutics, and telehealth POCT devices.
United States of America
AIMD
Akero Therapeutics, Inc. Logo
Clinical-stage company developing treatments for serious metabolic diseases like MASH.
United States of America
AKRO
Aladdin Healthcare Technologies SE Logo
Develops AI-powered tools for drug discovery and diagnostics for age-related conditions.
Germany
NMI
Alaunos Therapeutics, Inc. Logo
Clinical-stage immuno-oncology company developing TCR-T cell therapies for solid tumors.
United States of America
TCRT
Aligos Therapeutics, Inc. Logo
A clinical-stage biopharmaceutical company developing therapeutics for liver and viral diseases.
United States of America
ALGS

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.